| HTXD: Treatment: ARV Drugs |
$482,528,466 |
| HLAB: Laboratory Infrastructure |
$142,238,363 |
| HTXS: Treatment: Adult Treatment |
$131,901,036 |
| OHSS: Health Systems Strengthening |
$105,721,250 |
| HKID: Care: Orphans and Vulnerable Children |
$94,561,077 |
| HBHC: Care: Adult Care and Support |
$83,680,356 |
| HVCT: Testing: HIV Testing and Counseling |
$70,117,293 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission |
$63,849,755 |
| HVSI: Strategic Information |
$53,938,767 |
| HVOP: Sexual Prevention: Other Sexual Prevention |
$43,043,555 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful |
$40,002,956 |
| HMIN: Biomedical Prevention: Injection Safety |
$37,097,558 |
| HVTB: Care: TB/HIV |
$32,025,290 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision |
$27,011,642 |
| PDTX: Treatment: Pediatric Treatment |
$10,295,560 |
| HMBL: Biomedical Prevention: Blood Safety |
$7,550,689 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use |
$6,809,852 |
| PDCS: Care: Pediatric Care and Support |
$4,398,140 |
| HVMS: Management and Operations |
$1,549,744 |
